BDMD (Baird Medical Investment Holdings) Total Tax Payable: $3.10 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BDMD Baird Medical Investment Holdings Ltd BDMD
17 GF Score
Price $1.06
! 7 Warning Signs
View Full Analysis

What is Baird Medical Investment Holdings Total Tax Payable?

Baird Medical Investment Holdings BDMD -2.86% 17 Total Tax Payable is $3.10 Mil as of Dec. 2025. GuruFocus rates BDMD with a GF Score™ of 17/100. The stock has 7 warning signs investors should review.

Baird Medical Investment Holdings's Total Tax Payable for the quarter that ended in Dec. 2025 was $3.10 Mil.

Baird Medical Investment Holdings's quarterly Total Tax Payable declined from Dec. 2024 ($2.87 Mil) to Jun. 2025 ($2.45 Mil) but then increased from Jun. 2025 ($2.45 Mil) to Dec. 2025 ($3.10 Mil).

Baird Medical Investment Holdings's annual Total Tax Payable increased from Dec. 2023 ($0.77 Mil) to Dec. 2024 ($2.87 Mil) and increased from Dec. 2024 ($2.87 Mil) to Dec. 2025 ($3.10 Mil).


Baird Medical Investment Holdings Total Tax Payable Related Terms


Baird Medical Investment Holdings Total Tax Payable Historical Data

* Premium members only.

The historical data trend for Baird Medical Investment Holdings's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baird Medical Investment Holdings Total Tax Payable Chart

Baird Medical Investment Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Tax Payable
0.74 1.80 0.77 2.87 3.10

Baird Medical Investment Holdings Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Tax Payable Get a 7-Day Free Trial 0.77 0.21 2.87 2.45 3.10
BDMD
17GF Score
Baird Medical Investment Holdings Ltd BDMD
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Baird Medical Investment Holdings Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of $3.10 Mil mean?
Baird Medical Investment Holdings (BDMD) has a Total Tax Payable of $3.10 Mil as of Dec. 2025. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Baird Medical Investment Holdings and its competitors.
Is Baird Medical Investment Holdings' Total Tax Payable too high?
Baird Medical Investment Holdings' current Total Tax Payable is $3.10 Mil. Overall, Baird Medical Investment Holdings has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Baird Medical Investment Holdings' Total Tax Payable compare to TELA and NSPR?
Baird Medical Investment Holdings' Total Tax Payable of $3.10 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Medical Devices & Instruments company?
A good Total Tax Payable depends on the Medical Devices & Instruments industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Baird Medical Investment Holdings and its competitors. Baird Medical Investment Holdings's current Total Tax Payable is $3.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baird Medical Investment Holdings stock overvalued right now?
Baird Medical Investment Holdings (BDMD) has a current Total Tax Payable of $3.10 Mil. The current Total Tax Payable is $3.10 Mil. Baird Medical Investment Holdings' overall GF Score™ is 17/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For Baird Medical Investment Holdings (BDMD), the current Total Tax Payable is $3.10 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Baird Medical Investment Holdings Business Description

Address No.15 Rongtong Street, Room 202, 2nd Floor, Baide Building, Building 11, Yuexiu District, Guangzhou, CHN
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
17GF Score

Get the complete analysis for BDMD

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.06
Price